In neurodegenerative diseases, inflammasome activation, particularly the NLRP3 inflammasome activation, has been extensively studied for its role in AD and PD, but its specific pathogenic mechanisms in HD and ALS are not well understood. This evidence concerns the gene NLRP3 and Parkinson disease.